NYBC Ventures
Overview
NYBC Ventures is an early-stage life sciences investment fund dedicated to advancing innovations in blood and cellular therapies, and related technologies. The fund invests in therapeutics, devices, and cutting-edge technologies that address critical challenges in these fields. Its mission is to improve patient outcomes by supporting groundbreaking therapeutics, platforms, and collaborative efforts.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Catena Biosciences | Aug 2021 | Seed | Co-investor |
| Vitestro | Mar 2026 | Series B | Co-investor |
| KaloCyte, Inc. | Jul 2023 | Debt | Co-investor |
| Thymmune Therapeutics | Mar 2023 | Seed | Co-investor |
| City Therapeutics | Jun 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Meg Wood
Managing Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NYBC Ventures based?
NYBC Ventures is headquartered in Boston, Massachusetts, United States.
When was NYBC Ventures founded?
NYBC Ventures was founded in 2022.
How many portfolio companies does NYBC Ventures have?
NYBC Ventures has 13 portfolio companies in Caplight's dataset.
What are some companies in NYBC Ventures's portfolio?
Portfolio companies visible on Caplight include Catena Biosciences, Vitestro, KaloCyte, Inc., Thymmune Therapeutics, City Therapeutics.
What was NYBC Ventures's most recent investment shown here?
NYBC Ventures's most recent investment in this portfolio sample was in City Therapeutics in 2026.
What sectors does NYBC Ventures focus on?
NYBC Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does NYBC Ventures focus on?
NYBC Ventures typically invests at the MultiStage stage.
What is NYBC Ventures's AUM?
NYBC Ventures's assets under management are estimated between $0.0 and $50.0M.